These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 8221053)
61. Effects of lesions of the subthalamic nucleus/zona incerta area and dorsomedial striatum on attentional set-shifting in the rat. Tait DS; Phillips JM; Blackwell AD; Brown VJ Neuroscience; 2017 Mar; 345():287-296. PubMed ID: 27522961 [TBL] [Abstract][Full Text] [Related]
62. Attentional set-shifting in Parkinson's disease patients with freezing of gait-acquisition and discrimination set learning deficits at the background? Stefanova E; Ječmenica Lukić M; Ziropadja L; Marković V; Stojković T; Tomić A; Dragašević Mišković N; Kostić V J Int Neuropsychol Soc; 2014 Oct; 20(9):929-36. PubMed ID: 25307410 [TBL] [Abstract][Full Text] [Related]
63. Impaired concentration due to frontal lobe damage from two distinct lesion sites. Alexander MP; Stuss DT; Shallice T; Picton TW; Gillingham S Neurology; 2005 Aug; 65(4):572-9. PubMed ID: 16116118 [TBL] [Abstract][Full Text] [Related]
64. Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication. Cooper JA; Sagar HJ; Sullivan EV Neuropsychologia; 1993 Sep; 31(9):933-49. PubMed ID: 8232850 [TBL] [Abstract][Full Text] [Related]
65. Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease. Madhyastha TM; Askren MK; Zhang J; Leverenz JB; Montine TJ; Grabowski TJ Brain; 2015 Sep; 138(Pt 9):2672-86. PubMed ID: 26173859 [TBL] [Abstract][Full Text] [Related]
66. Memory and skill acquisition in Parkinson's disease and frontal lobe dysfunction. Daum I; Schugens MM; Spieker S; Poser U; Schönle PW; Birbaumer N Cortex; 1995 Sep; 31(3):413-32. PubMed ID: 8536473 [TBL] [Abstract][Full Text] [Related]
67. [Cognitive dysfunction in Parkinson's disease]. Maruyama T Nihon Rinsho; 2000 Oct; 58(10):2007-15. PubMed ID: 11068439 [TBL] [Abstract][Full Text] [Related]
68. Normal release from proactive interference in untreated patients with Parkinson's disease. Sagar HJ; Sullivan EV; Cooper JA; Jordan N Neuropsychologia; 1991; 29(11):1033-44. PubMed ID: 1775225 [TBL] [Abstract][Full Text] [Related]
69. Enhanced frontal function in Parkinson's disease. Cools R; Miyakawa A; Sheridan M; D'Esposito M Brain; 2010 Jan; 133(Pt 1):225-33. PubMed ID: 19995871 [TBL] [Abstract][Full Text] [Related]
76. The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD. Rane P; Shields J; Heffernan M; Guo Y; Akbarian S; King JA Neuropharmacology; 2012 Jun; 62(7):2409-12. PubMed ID: 22353286 [TBL] [Abstract][Full Text] [Related]
77. Declarative memory in early Parkinson's disease: serial position learning effects. Stefanova ED; Kostic VS; Ziropadja LJ; Ocic GG; Markovic M J Clin Exp Neuropsychol; 2001 Oct; 23(5):581-91. PubMed ID: 11778635 [TBL] [Abstract][Full Text] [Related]
78. An investigation of the phenomenon of "set" in Parkinson's disease. Brown RG; Marsden CD Mov Disord; 1988; 3(2):152-61. PubMed ID: 3221902 [TBL] [Abstract][Full Text] [Related]
79. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Downes JJ; Roberts AC; Sahakian BJ; Evenden JL; Morris RG; Robbins TW Neuropsychologia; 1989; 27(11-12):1329-43. PubMed ID: 2615934 [TBL] [Abstract][Full Text] [Related]